Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

If you’re the type of person who likes to maintain Inbox Zero, or who recently went and tidied up their Gmail inbox to get every email marked as read, you may come across a frustrating situation where ...

Eisai is an established developer of medicines to treat Alzheimer's dementia, most recently claiming approval for its Biogen-partnered anti-amyloid therapy Leqembi (lecanemab), but has also long ...